The Open Arthritis Journal · 2011 · 20 citations · 35 references
Life SciencesImmunologyInternal MedicineAutoimmunityClinical ImmunologyRheumatologyAutoantibodiesAutoimmune DiseasesAutoimmune Hematologic DiseaseAutoimmune Rheumatic DiseasesAutoimmune VasculitisGranulomatous InflammationAnti-myeloperoxidase AntibodiesAnti-neutrophil Cytoplasmic AntibodiesAnti-proteinase 3 AntibodiesAntineutrophil AntibodiesAntineutrophil Cytoplasmic AntibodiesAutoimmune Vasculitis PathologyVasculitis PathogenesisVasculitis Treatment
Granulomatosis with polyangiitis (formerly Wegener's) (GPA) and microscopic polyangiitis (MPA) share many clinical and pathological features, including antineutrophil cytoplasmic antibodies (ANCA) directed against either proteinase 3 (PR3) or myeloperoxidase (MPO). These two "ANCA-associated" vasculitides (AAV) are associated with a high mortality in untreated patients, substantial morbidity from standard therapies, and a significant risk of disease relapse.
35
Wegener Granulomatosis: An Analysis of 158 Patients
Gary S. Hoffman, Gail S. Kerr, Randi Y. Leavitt et al. · Annals of Internal Medicine · 1992 · 2.9K citations
Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis
John H. Stone, Peter A. Merkel, Robert Spiera et al. · New England Journal of Medicine · 2010 · 2.7K citations · Full text
Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20
ME Reff, K Carner, KS Chambers et al. · Blood · 1994 · 1.9K citations · Full text
Life Sciences, Immunology, Pathology +14